kazi's been spot on for over a year. Read here>>>
my
kazi's been spot on for over a year. Read here>>>
my research shows someone "in the room" (not Q3) has been so very very wrong about everything kazi tried to convince the same someone about.
it looks like she has been correct about everything except the RS (which will most-likely be needed again soon).
meanwhile here's drugmanrx resume of rights and wrongs.
R/S cancel - right
see list of wrongs below:
Medrecycler still being a subsidiary as posted in Novemeber-December 2022 and January and February 2023 before 10-K.
50 mil Loan was already approved as posted in January-February-March 2023
Ri transit contract NOT being terminated as posted last July-August-September-October 2022
Foxess mass production starting July 2022 as posted in May-June 2022
PT.IDN already making SPP brand name solar panels (April 2022) as posted in April-May-June 2022.
Texas being the first location for the PT.IDN/SPP solar panel plant as posted in June-July 2022 "don't mess with..."
Significant revenue showing up in Q3 2022 (i.e. Q3 in the room) as posted in August-September 2022
Foxess late 2022 and early 2023 shipments being Spp product shipments as posted in March 2023 and May 2023
EPC already owning the Elba, AL property based on property purchase agreement as posted in April 2023
Spp sales teams set up in Florida and Texas as posted in April 2023
foxess global partner link was gonna result in foxess sales and marketing campaign (leading to Spp revenue) in the summer of 2022...then again in the fall of 2022...and then again in the winter of 2023 as posted numerous times over the past 8 months.
the long list of drugman's wrongs are proven by the 12/31/22 scoreboard: $4,700 in monthly revenue. just a pathetic pom-pom campaign for over 16 months now
kazi said to say hello.
kinownsentme
in my humble opinion
cheers
Sun Pacific Holding Corp. (SNPW) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
STING Agonists: The Next Frontier in Glioblastoma Treatment? Out there in the weeds of immunotherapy, ImmunoGenesis is gearing up for its moment at the SITC 2026 Annual Meeting with its STING agonist, IMGS-203. The stakes are skyscraper-high as this novel treatment makes a play against recurrent glioblastoma (GBM)—one tough cookie in the realm of brain cancers....
Continue Reading
The Rise of Peptide Education Imagine you're wading through a bog of health trends. That's how it feels trying to get a grip on peptide therapies these days, right? Luckily, PeptideWorld, powered by e?vita Health, is here to toss you a lifeline. They're transforming the landscape with a mission to ditch the marketing mumbo-jumbo for hard science. Their pitch?...
Continue Reading
Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....
Continue Reading
Basildon's New Housing Beacon Nears Completion No two construction milestones are the same, and Starlight Investments sure knows how to make theirs count. Reaching the skies with their project 'The Mercantile' in Basildon, the company has announced topping out—a significant phase in their build-to-rent development saga. With the structural peak reached, we're talking...
Continue Reading
Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...
Continue Reading
Paving the Future with Patents Ah, patents. Like stock dividends for the tech world—they don’t change everything outright but can signal some mighty good things ahead. This time around, it’s Satisfi Labs who are in the spotlight. They’ve bagged not one, but two shiny U.S. patents to bolster what they’re calling Satisfi Forward. Honestly, it sounds like a...
Continue Reading
Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...
Continue Reading
Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...
Continue Reading
A Dual Milestone: Leadership and Recognition In an industry chock-full of buzzwords, New Story’s latest moves cut through the noise. They've just announced Adam Drudge as their new Chief People Officer, and wouldn't you know it, they've snagged their third straight Most Loved Workplace® recognition for 2026. When a special ed company starts making waves like this,...
Continue Reading
Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing the Arlo Wired Floodlight Camera Arlo Technologies, Inc. (NYSE: ARLO), known for its leading smart home security solutions, has introduced an enhanced Wired Floodlight Camera. This innovative all-in-one DIY security solution builds on the company's successful line of wire-free floodlights, leveraging advanced technology to ensure that your outdoor spaces are...
Continue Reading
Bruce Berkowitz's Significant Sell-Off of St. Joe Shares Recently, it was reported that BRUCE BERKOWITZ, a notable stakeholder of St. Joe (NYSE: JOE), executed a significant sell-off of his shares. According to a filing with the SEC, Berkowitz sold 71,900 shares at a total value of approximately $4.48 million. Such actions from insiders often draw the attention of...
Continue Reading
Yaamava' Resort & Casino Continues to Impress Critics and Guests Year after year, Yaamava' Resort & Casino at San Manuel has made a remarkable mark in the gaming industry, consistently rising to the top of prestigious rankings. Most recently, the resort secured its status once again by being voted the Best Overall Casino Outside of Las Vegas and Best Native American...
Continue Reading
Maro Secures Significant Seed Funding to Combat Cybersecurity Risks Maro, an innovative player in cognitive security, has successfully raised $4.3 million from Downing Capital Group. This funding is set to empower companies to better manage human risks associated with cybersecurity, transforming the way organizations deal with elements such as social engineering, insider...
Continue Reading
Understanding B7-H3 Inhibitors and Their Impact on Cancer Treatment The B7-H3 inhibitors market is rapidly emerging as a transformative force in oncology. The significant increase in investment from pharmaceutical giants alongside a rising number of cancer diagnoses has heightened interest and research in this area. This class of inhibitors aims to target the B7-H3...
Continue Reading